Evidence map›Paper›PMID 25606365›Full record

ArticleIntractable & rare diseases research2014

Distribution of AGG interruption patterns within nine world populations.

Carolyn M Yrigollen, Stefan Sweha, Blythe Durbin-Johnson, Lili Zhou, Elizabeth Berry-Kravis, Isabel Fernandez-Carvajal, Sultana Mh Faradz, Khaled Amiri, Huda Shaheen, Roberta Polli and 5 more

Abstract read
In one paragraph

Article in Intractable & rare diseases research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Screening of CGG Trinucleotide Repeats WithinJournal of the Korean Academy of Child and Adolescent Psychiatry · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Carolyn M YrigollenDepartment of Biochemistry and Molecular Medicine, University of California Davis, School of Medicine, Davis, CA, USA;
Stefan SwehaDepartment of Biochemistry and Molecular Medicine, University of California Davis, School of Medicine, Davis, CA, USA;
Blythe Durbin-JohnsonDepartment of Public Health Sciences, University of California Davis, School of Medicine, Davis, CA, USA;
Lili ZhouDepartment of Pediatrics, Neurological Sciences, Biochemistry, Rush University Medical Center, Chicago, IL, USA;
Elizabeth Berry-KravisDepartment of Pediatrics, Neurological Sciences, Biochemistry, Rush University Medical Center, Chicago, IL, USA;
Isabel Fernandez-CarvajalLaboratorio de Enfermedades genéticas y cribado neonatal, Departamento de Genetica Molecular de la Enfermedad, Instituto de Biologìa y Genética Molecular Universidad de Valladolid-CSIC, Valladolid, Spain;
Sultana Mh FaradzCenter for Biomedical Research, Diponegoro University, Semarang, Central Java, Indonesia;
Khaled AmiriDepartment of Biology, College of Science, United Arab University, United Arab Emirates;
Huda ShaheenDepartment of Biology, College of Science, United Arab University, United Arab Emirates;
Roberta PolliLaboratory of Molecular Genetics of Neurodevelopment, Department of Women's and Children's Health, University of Padova, Italy;
Luis Murillo-BonillaAutonomous University of Guadalajara, Faculty of Medicine, Guadalajara, Mexico;
Gabriel de Jesus Silva ArevaloGenetic and Neurometabolic Clinic, Obras Sociales Santo Hermano Pedro, Antigua Guatemala. Center by Biomedical Research, Medicine school San Carlos University, Guatemala Central America;
Patricia CogramBiomedicine Division, Fraunhofer Chile Research Foundation, Santiago, Chile;
Alessandra MurgiaLaboratory of Molecular Genetics of Neurodevelopment, Department of Women's and Children's Health, University of Padova, Italy;
Flora TassoneDepartment of Biochemistry and Molecular Medicine, University of California Davis, School of Medicine, Davis, CA, USA; ; M.I.N.D. Institute, University of California Davis Medical Center, Davis, CA, USA.

Funding

Restoring FMRP Phenotypes Frpm Temporal Regional and Splice- Isoforms VarationsP30HD002274 · NICHD · UNIVERSITY OF WASHINGTON · PI GURALNICK, MICHAEL J · 1985 to 2013
$33.6M
UC Davis Clinical and Translational Science CenterUL1TR000002 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERGLUND, LARS F · 2012 to 2015
$12.2M
Rodent Behavior CoreU54HD079125 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI ABBEDUTO, LEONARD J. · 2013 to 2019
$8.5M
NCATS NIH HHS UL1 TR000002NICHD NIH HHS P30 HD002274NICHD NIH HHS U54 HD079125
6 · The paper itself

Abstract

The CGG trinucleotide repeat within the FMR1 gene is associated with multiple clinical disorders, including fragile X-associated tremor/ataxia syndrome, fragile X-associated primary ovarian insufficiency, and fragile X syndrome. Differences in the distribution and prevalence of CGG repeat length and of AGG interruption patterns have been reported among different populations and ethnicities. In this study we characterized the AGG interruption patterns within 3,065 normal CGG repeat alleles from nine world populations including Australia, Chile, United Arab Emirates, Guatemala, Indonesia, Italy, Mexico, Spain, and United States. Additionally, we compared these populations with those previously reported, and summarized the similarities and differences. We observed significant differences in AGG interruption patterns. Frequencies of longer alleles, longer uninterrupted CGG repeat segments and alleles with greater than 2 AGG interruptions varied between cohorts. The prevalence of fragile X syndrome and FMR1 associated disorders in various populations is thought to be affected by the total length of the CGG repeat and may also be influenced by the AGG distribution pattern. Thus, the results of this study may be important in considering the risk of fragile X-related conditions in various populations.

Indexed as

AGG interruptionsCGG repeatethnicityexpansionFMR1 allele

Identifiers

PMID25606365
PMCPMC4298645

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.